Cargando…

HYPERDYNAMIC LEFT VENTRICULAR EJECTION FRACTION IS A POOR PROGNOSTIC SIGN IN COVID-19 INFECTION

Detalles Bibliográficos
Autores principales:	Ruge, Max, Gomez, Joanne Michelle D., de Lavallaz, Jeanne Du Fay, Simmons, J. Alan, Canzolino, Jessica, Volgman, Annabelle Santos, Williams, Kim, Rao, Anupama, Marinescu, Karolina, Suboc, Tisha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Cardiology Foundation. Published by Elsevier Inc. 2021
Materias:	Spotlight on Special Topics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091351/ http://dx.doi.org/10.1016/S0735-1097(21)04505-8

Ejemplares similares

INITIAL TROPONIN LEVEL AS A COVID-19 ILLNESS PROGNOSTICATOR
por: Ruge, Max, et al.
Publicado: (2021)

Hyperdynamic left ventricular ejection fraction is associated with higher mortality in COVID-19 patients
por: Rahman, Annas, et al.
Publicado: (2022)

PERSONALIZING THE OPTIMAL CARDIAC TROPONIN THRESHOLD FOR COVID-19 PROGNOSTICATION BASED ON PRE-EXISTING COMORBIDITIES
por: Ruge, Max, et al.
Publicado: (2022)

ASSOCIATION BETWEEN IN-HOSPITAL MORTALITY AND ACE/ARB INHIBITOR USAGE
por: Ruge, Max, et al.
Publicado: (2022)

ECHOCARDIOGRAPHIC AND BIOMARKER PREDICTORS FOR IN-HOSPITAL MORTALITY IN COVID-19 DISEASE
por: Gomez, Joanne Michelle D., et al.
Publicado: (2021)

PREVALENCE OF PRE-EXISTING ATRIAL FIBRILLATION AND ASSOCIATION WITH IN-HOSPITAL MORTALITY IN PATIENTS WITH COVID-19
por: Sanders, David, et al.
Publicado: (2022)

CLINICAL CHARACTERISTICS OF NEUROLOGICAL DISEASE AND COVID-19
por: Thakkar, Kajal, et al.
Publicado: (2022)

CHARACTERICS OF HISPANIC, NON HISPANIC WHITE AND NON-HISPANIC BLACK PATIENTS SCREENED AND HOSPITALIZED FOR COVID-19 IN CHICAGO, USA
por: Fugar, Setri, et al.
Publicado: (2021)

CLINICAL PREDICTORS OF COAGULOPATHY EVENTS IN HOSPITALIZED PATIENTS WITH COVID-19 DISEASE
por: Derbas, Laith, et al.
Publicado: (2021)

Prognostic value of H(2)FPEF score in COVID-19
por: Patel, Priya, et al.
Publicado: (2022)

The prognostic value of cardiac troponin for 60 day mortality and major adverse events in COVID-19 patients
por: Ruge, Max, et al.
Publicado: (2021)

Impact of pre-existing heart failure on 60-day outcomes in patients hospitalized with COVID-19
por: Ruge, Max, et al.
Publicado: (2021)

Cardiovascular findings on chest computed tomography associated with COVID-19 adverse clinical outcomes()
por: Planek, Maria Isabel Camara, et al.
Publicado: (2021)

Echocardiographic predictors of mortality and morbidity in COVID-19 disease using focused cardiovascular ultrasound
por: Gomez, Joanne Michelle D., et al.
Publicado: (2022)

Clinical outcomes of COVID-19 infection in patients with pre-existing cardiovascular disease
por: Kerolos, Mina Medhat, et al.
Publicado: (2022)

Hyperdynamic ejection fraction in the critically ill patient
por: Paonessa, JR, et al.
Publicado: (2014)

IMPACT OF BASELINE LEFT VENTRICULAR EJECTION FRACTION ON OUTCOMES IN COVID-19 INFECTION
por: Morin, Daniel P., et al.
Publicado: (2021)

BODY MASS INDEX, INFLAMMATION AND SEVERITY IN HOSPITALIZED COVID-19 PATIENTS: RESULTS FROM A CHICAGO AND MADRID RETROSPECTIVE COHORT STUDY
por: Park, Aaron, et al.
Publicado: (2023)

Hyperdynamic left ventricular ejection fraction in the intensive care unit
por: Paonessa, Joseph R., et al.
Publicado: (2015)

LEFT VENTRICULAR GLOBAL LONGITUDINAL STRAIN IN PATIENTS WITH PREVIOUS NON-HOSPITALIZED MILD TO MODERATE COVID-19, AND PRESERVED LEFT VENTRICULAR EJECTION FRACTION
por: Tagliamonte, Ercole, et al.
Publicado: (2021)

Editorial commentary: COVID-19 as a cardiovascular disease risk factor
por: Oktay, Ahmet Afşin, et al.
Publicado: (2022)

IDF21-0311 Pre-Admission, Diabetic Glycemic Control on 60-Day Mortality and Major Adverse Cardiovascular Events from COVID-19
por: Ruge, M., et al.
Publicado: (2022)

COVID-19-associated takotsubo cardiomyopathy
por: Gomez, Joanne Michelle Dumlao, et al.
Publicado: (2020)

ASSOCIATION OF MCCONNELL’S SIGN WITH MORTALITY AMONG PATIENTS HOSPITALIZED WITH COVID-19
por: Yeo, Ilhwan, et al.
Publicado: (2021)

Inflammatory pathways in heart failure with preserved left ventricular ejection fraction: implications for future interventions
por: Pugliese, Nicola Riccardo, et al.
Publicado: (2022)

Comorbidities in heart failure with preserved ejection fraction
por: Deichl, Andrea, et al.
Publicado: (2022)

Pearls and Purple: The Dawn of a Modern Age
por: Tracy, Melissa, et al.
Publicado: (2021)

LONG-TERM OUTCOMES OF VETERANS WITH A DIAGNOSIS OF HEART FAILURE AFTER CORONAVIRUS-2019 (COVID-19) INFECTION
por: Khetpal, Vishal, et al.
Publicado: (2022)

Management strategies in heart failure with preserved ejection fraction
por: Wintrich, Jan, et al.
Publicado: (2022)

Usefulness of “heart‐shaped sign” during “spaghetti twisting” technique in transvenous lead extraction
por: Okada, Takuya, et al.
Publicado: (2023)

PATIENT SATISFACTION WITH VIRTUAL HEART FAILURE CARE DURING THE INITIAL COVID-19 SURGE
por: Newman, Seth, et al.
Publicado: (2021)

The Role of Angiotensin‐Converting Enzyme Inhibitors and β‐Blockers in Primary Prevention of Cardiac Dysfunction in Breast Cancer Patients
por: Brown, Sherry‐Ann, et al.
Publicado: (2020)

Sex Differences in Heart Failure With Preserved Ejection Fraction
por: Sotomi, Yohei, et al.
Publicado: (2021)

CLINICAL CHARACTERISTICS AND OUTCOMES IN CARDIO-ONCOLOGY PATIENTS WITH COVID-19: ANALYSIS FROM THE COVID-19 AND CANCER CONSORTIUM (CCC19) DATABASE
por: Moey, Melissa YY, et al.
Publicado: (2021)

Tropical Endomyocardial Fibrosis
por: Sutter, Joanne S., et al.
Publicado: (2020)

Exploratory Review of the Role of Statins, Colchicine, and Aspirin for the Prevention of Radiation‐Associated Cardiovascular Disease and Mortality
por: Camara Planek, Maria Isabel, et al.
Publicado: (2020)

Clathrin: Bender or bystander?
por: Stachowiak, Jeanne C.
Publicado: (2022)

Termination of slow‐fast atrioventricular reentrant tachycardia by a single cryoablation of the slow pathway guided by a fractionation map
por: Wakamatsu, Yuji, et al.
Publicado: (2023)

The future of heart failure with preserved ejection fraction: Deep phenotyping for targeted therapeutics
por: Heinzel, Frank R., et al.
Publicado: (2022)

RISK PREDICTORS FOR MYOCARDIAL INJURY IN SEVERE COVID-19
por: Nascimento, Jorge H.P., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_09jbhbaeuevbv63f7qo0s4qlpf